NYSEAMERICAN:CRHMCRH Medical Stock Price, Forecast & News

$1.90

-0.03 (-1.55 %)

(As of 06/2/2020 01:23 PM ET)

Add

Compare

Today's Range

$1.87

Now: $1.90▼

$1.95

50-Day Range N/A

52-Week Range

$0.86

Now: $1.90▼

$4.43

Volume3,766 shs

Average Volume123,018 shs

Market Capitalization$136.00 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

CRH Medical Corporation provides various products and services to gastroenterologists in the United States and Canada. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology for treating various grades of hemorrhoid. The company also offers anesthesia services for patients undergoing endoscopic procedures. It distributes the CRH O'Regan system, treatment protocols, and operational and marketing expertise as a turnkey package directly to physicians. The company was formerly known as Medsurge Medical Products Corp. and changed its name to CRH Medical Corporation in April 2006. CRH Medical Corporation was founded in 2000 and is headquartered in Vancouver, Canada.

Beat the Market (BTM) Rank^™

3.4 Analyst's Opinion

Consensus Rating
CRH Medical has received a consensus rating of Buy. The company's average rating score is 2.75, and is based on 3 buy ratings, 1 hold rating, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $4.00, CRH Medical has a potential upside of 110.0% from its current price of $1.91.
Amount of Analyst Coverage
CRH Medical has only been the subject of 3 research reports in the past 90 days.

2.6 Community Rank

Outperform Votes
CRH Medical has received 204 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
CRH Medical has received 196 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
CRH Medical has received 51.00% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about CRH Medical and other stocks. Vote “Outperform” if you believe CRHM will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CRHM will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
CRH Medical does not currently pay a dividend.
Dividend Growth
CRH Medical does not have a long track record of dividend growth.

3.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, CRH Medical insiders have bought more of their company's stock than they have sold. Specifically, they have bought $48,600.00 in company stock and sold $0.00 in company stock.

0.0 Earnings and Valuation

Overall Beat the Market Rank^™

1.80 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN

Industry Medical Instruments & Supplies

Sub-IndustryN/A

SectorMedical

Current SymbolNYSEAMERICAN:CRHM

Previous SymbolNYSEARCA:CRHM

CUSIPN/A

CIKN/A

Webinvestors.crhsystem.com

Phone+1-604-6331440

Debt

Debt-to-Equity RatioN/A

Current RatioN/A

Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / Cash FlowN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Employees112

Outstanding Shares71,579,000

Market Cap$136.00 million

Next Earnings Date7/29/2020 (Estimated)

OptionableNot Optionable

Receive CRHM News and Ratings via Email

Sign-up to receive the latest news and ratings for CRHM and its competitors with MarketBeat's FREE daily newsletter.

CRH Medical (NYSEAMERICAN:CRHM) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of CRH Medical?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CRH Medical in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for CRH Medical.

When is CRH Medical's next earnings date?

CRH Medical is scheduled to release its next quarterly earnings announcement on Wednesday, July 29th 2020. View our earnings forecast for CRH Medical.

How were CRH Medical's earnings last quarter?

CRH Medical Corp (NYSEAMERICAN:CRHM) released its earnings results on Tuesday, May, 12th. The company reported ($0.03) earnings per share for the quarter, missing analysts' consensus estimates of $0.01 by $0.04. The firm earned $25.46 million during the quarter, compared to the consensus estimate of $28.70 million. View CRH Medical's earnings history.

What price target have analysts set for CRHM?

4 analysts have issued 1-year price objectives for CRH Medical's stock. Their forecasts range from $4.00 to $4.00. On average, they expect CRH Medical's stock price to reach $4.00 in the next twelve months. This suggests a possible upside of 110.0% from the stock's current price. View analysts' price targets for CRH Medical.

Has CRH Medical been receiving favorable news coverage?

Press coverage about CRHM stock has been trending very positive on Tuesday, InfoTrie Sentiment reports. The research group ranks the sentiment of news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. CRH Medical earned a daily sentiment score of 3.5 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the next few days. View the latest news aboutCRH Medical.

Are investors shorting CRH Medical?

CRH Medical saw a decrease in short interest during the month of May. As of May 15th, there was short interest totaling 34,200 shares, a decrease of 26.5% from the April 30th total of 46,500 shares. Based on an average daily trading volume, of 144,500 shares, the days-to-cover ratio is currently 0.2 days. Currently, 0.1% of the shares of the company are sold short. View CRH Medical's Current Options Chain.

Who are some of CRH Medical's key competitors?

Some companies that are related to CRH Medical include Advanced Medical Solutions Group (AMS), Clover (CLV), InfuSystem (INFU), Tristel (TSTL), Bovie Medical (BVX), CRH Medical (CRH), Retractable Technologies (RVP), Omega Diagnostics Group (ODX), SDI (SDI), Milestone Scientific (MLSS), Daxor (DXR), Daxor (DXR), IsoRay (ISR), IsoRay (ISR) and TSO3 (TOS). View all competitors.

What other stocks do shareholders of CRH Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CRH Medical investors own include CRH Medical (CRH), AcelRx Pharmaceuticals (ACRX), Extreme Networks (EXTR), Alimentation Couche-Tard (ATD.B), Dollarama (DOL), NovaBay Pharmaceuticals (NBY), NovaBay Pharmaceuticals (NBY), Pieris Pharmaceuticals (PIRS), Palatin Technologies (PTN) and Ring Energy (REI).

Who are CRH Medical's key executives?

CRH Medical's management team includes the following people:

Mr. Edward Wright, CEO & Non-Independent Director (Age 56)
Mr. Richard K. Bear, CFO & Corp. Sec. (Age 56)
Mr. James Kreger, Pres of CRH Anesthesia Management
Ms. Kettina Cordero, Director of Investor Relations

What is CRH Medical's stock symbol?

CRH Medical trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "CRHM."

Who are CRH Medical's major shareholders?

CRH Medical's stock is owned by a number of institutional and retail investors. Top institutional investors include Morgan Stanley (4.08%), Morgan Stanley (4.08%), Connor Clark & Lunn Investment Management Ltd. (2.91%), JPMorgan Chase & Co. (1.49%), Acadian Asset Management LLC (1.08%) and Hillsdale Investment Management Inc. (0.38%). Company insiders that own CRH Medical stock include David Allan Johnson and James Kreger. View institutional ownership trends for CRH Medical.

Which institutional investors are selling CRH Medical stock?

CRHM stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, Morgan Stanley, JPMorgan Chase & Co., Connor Clark & Lunn Investment Management Ltd., Hillsdale Investment Management Inc., and Wedge Capital Management L L P NC. View insider buying and selling activity for CRH Medical.

Which institutional investors are buying CRH Medical stock?

CRHM stock was acquired by a variety of institutional investors in the last quarter, including Acadian Asset Management LLC, Mackenzie Financial Corp, Spark Investment Management LLC, Deutsche Bank AG, and 1832 Asset Management L.P.. View insider buying and selling activity for CRH Medical.

How do I buy shares of CRH Medical?

Shares of CRHM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is CRH Medical's stock price today?

One share of CRHM stock can currently be purchased for approximately $1.91.

How big of a company is CRH Medical?

CRH Medical has a market capitalization of $136.36 million. CRH Medical employs 112 workers across the globe.

What is CRH Medical's official website?

The official website for CRH Medical is investors.crhsystem.com.

How can I contact CRH Medical?

CRH Medical's mailing address is 57B - 999 Canada Place World Trade Center, VANCOUVER, BC V6C 3E1, Canada. The company can be reached via phone at +1-604-6331440.

This page was last updated on 6/2/2020 by MarketBeat.com Staff